PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.81
ESG score 90-95% of ADAP's 59.92. Bill Ackman would demand clear ESG improvement catalysts.
51.40
Environmental score 90-95% of ADAP's 54.77. Bill Ackman would demand clear environmental improvement catalysts.
58.59
Social score 90-95% of ADAP's 64.45. Bill Ackman would demand clear social improvement catalysts.
60.45
Similar governance score to ADAP's 60.54. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.